title: Molecular targets in cancer therapy.
abstract: 24th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics' 6-9 November 2012, Dublin, Ireland The EORTC-NCI-AACR Symposium is an annual meeting, jointly hosted by the European Organization for Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research, to encourage exchange of information, dialogue and collaboration between investigators from the US, Europe and the world over regarding the development of novel cancer therapeutics. This meeting is hosted on alternate years in the US and Europe. This year's symposium, held in Dublin, Ireland, focused on the identification of novel targets, strategies for biomarker development and trial designs to expedite development of new therapies and improve patient selection. With over 30 oral presentations, more than 600 poster presentations and over 2000 participants, the meeting covered all the major aspects of oncology drug development, including the integration of newer platforms for the development of biomarkers.
authors.affiliation: Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. kummars@mail.nih.gov
authors.forename: Shivaani
authors.initials: S
authors.lastname: Kummar
authors.forename: James H
authors.initials: JH
authors.lastname: Doroshow
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D055808:Drug Discovery / Q000379:methods; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor